Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nerve; Lesion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05172232
What this trial is testing

Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions

Who this might be right for
Malignant Melanoma
Linkoeping University 231
Not applicableStudy completedNCT05088096
What this trial is testing

Translation, Cultural Adaptation and Psychometric Properties of Urdu Version of Upper Limb Functional Index Questionnaire in Patients With Upper Limb Musculoskeletal Disorders

Who this might be right for
Upper Limb Nerve LesionReliabilityValidity
University of Lahore 250
Not applicableStudy completedNCT06721130
What this trial is testing

Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot Study

Who this might be right for
Cavernous Sinus SyndromeCavernous Sinus MeningiomaCavernous Sinus Lesions
Post Graduate Institute of Medical Education and Research, Chandigarh 54
Not applicableEnded earlyNCT05266430
What this trial is testing

Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)

Who this might be right for
Choroidal MelanomaIndeterminate Lesions
Aura Biosciences 2
Testing effectiveness (Phase 2)Ended earlyNCT02466074
What this trial is testing

Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
The University of Texas Health Science Center, Houston 5
Early research (Phase 1)Study completedNCT01119599
What this trial is testing

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Acoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more
National Cancer Institute (NCI) 22
Not applicableUnknownNCT06498804
What this trial is testing

The Blood Patch in the Management of Intracranial Hypotension

Who this might be right for
Intracranial Hypotension
University Hospital, Strasbourg, France 50
Not applicableEnded earlyNCT00991991
What this trial is testing

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Case Comprehensive Cancer Center 5
Not applicableNot Yet RecruitingNCT07523373
What this trial is testing

Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch

Who this might be right for
Parotid Gland TumorFacial and Neck Rhytides
Sheba Medical Center 20
Not applicableStudy completedNCT03094273
What this trial is testing

Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi

Who this might be right for
Dysplastic Nevi
NYU Langone Health 138
Very early researchUnknownNCT04897542
What this trial is testing

Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
First Affiliated Hospital of Fujian Medical University 100
Not applicableStudy completedNCT04507048
What this trial is testing

Passive Versus Active Educational Interventions for Melanoma Recognition

Who this might be right for
Educational ProblemsMelanoma (Skin)
Azienda USL Reggio Emilia - IRCCS 560
Testing effectiveness (Phase 2)Study completedNCT04796194
What this trial is testing

Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma

Who this might be right for
Advanced Melanoma
Lytix Biopharma AS 23
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Not applicableStudy completedNCT07757386
What this trial is testing

MelaMEd Online Training for General Practitioners to Improve Melanoma Detection and Management

Who this might be right for
Cutaneous Melanoma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,531
Large-scale testing (Phase 3)Study completedNCT00306683
What this trial is testing

Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions

Who this might be right for
Hypothalamic-pituitary LesionsCraniopharyngiomas
Assistance Publique - Hôpitaux de Paris 40
Testing effectiveness (Phase 2)Ended earlyNCT05199155
What this trial is testing

Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist

Who this might be right for
Nerve InjuryNerve Lesion
TBF Genie Tissulaire 12
Testing effectiveness (Phase 2)WithdrawnNCT01952886
What this trial is testing

Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients

Who this might be right for
Malignant Glioma
Duke University
Not applicableStudy completedNCT00395122
What this trial is testing

Optical Coherence Tomography Measurements in Eyes With Band Atrophy

Who this might be right for
Vision Disorders
University of Sao Paulo 30
Not applicableStudy completedNCT04788030
What this trial is testing

Reconstruction of Digital Nerve Lesions With Muscle-in-Vein Conduits

Who this might be right for
Peripheral Nerve Injury Upper Limb
BG Trauma Center Tuebingen 37
Next Page